Literature DB >> 12081814

Too little vitamin D in premenopausal women: why should we care?

Michael F Holick.   

Abstract

Entities:  

Keywords:  Non-programmatic

Mesh：

Substances：

Year:  2002        PMID： 12081814     DOI： 10.1093/ajcn/76.1.3

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN： 0002-9165            Impact factor:   7.045


× No keyword cloud information.
  19 in total

1.  1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model.

Authors:  Sunil K Halder; Chakradhari Sharan; Ayman Al-Hendy
Journal:  Biol Reprod       Date:  2012-04-19       Impact factor: 4.285

2.  Determination of vitamin D in relation to body mass index and race in a defined population of black and white women.

Authors:  Ponjola Coney; Laurence M Demers; William C Dodson; Allen R Kunselman; Gwinnett Ladson; Richard S Legro
Journal:  Int J Gynaecol Obstet       Date:  2012-07-18       Impact factor: 3.561

3.  Paricalcitol, a vitamin d receptor activator, inhibits tumor formation in a murine model of uterine fibroids.

Authors:  Sunil K Halder; Chakradhari Sharan; Omar Al-Hendy; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2014-06-12       Impact factor: 3.060

Review 4.  Role of vitamin D in uterine fibroid biology.

Authors:  Soumia Brakta; Justin S Diamond; Ayman Al-Hendy; Michael P Diamond; Sunil K Halder
Journal:  Fertil Steril       Date:  2015-06-13       Impact factor: 7.329

Review 5.  Vitamin D supplementation for women during pregnancy.

Authors:  Luz Maria De-Regil; Cristina Palacios; Ali Ansary; Regina Kulier; Juan Pablo Peña-Rosas
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 6.  The role of vitamin D in cancer prevention.

Authors:  Cedric F Garland; Frank C Garland; Edward D Gorham; Martin Lipkin; Harold Newmark; Sharif B Mohr; Michael F Holick
Journal:  Am J Public Health       Date:  2005-12-27       Impact factor: 9.308

7.  Three-phase model harmonizes estimates of the maximal suppression of parathyroid hormone by 25-hydroxyvitamin D in persons 65 years of age and older.

Authors:  Ramón A Durazo-Arvizu; Bess Dawson-Hughes; Christopher T Sempos; Elizabeth A Yetley; Anne C Looker; Guichan Cao; Susan S Harris; Vicki L Burt; Alicia L Carriquiry; Mary Frances Picciano
Journal:  J Nutr       Date:  2010-01-20       Impact factor: 4.798

8.  Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Authors:  Lisa Gallicchio; Kathy J Helzlsouer; Wong-Ho Chow; D Michal Freedman; Susan E Hankinson; Patricia Hartge; Virginia Hartmuller; Chinonye Harvey; Richard B Hayes; Ronald L Horst; Karen L Koenig; Laurence N Kolonel; Francine Laden; Marjorie L McCullough; Dominick Parisi; Mark P Purdue; Xiao-Ou Shu; Kirk Snyder; Rachael Z Stolzenberg-Solomon; Shelley S Tworoger; Arti Varanasi; Jarmo Virtamo; Lynne R Wilkens; Yong-Bing Xiang; Kai Yu; Anne Zeleniuch-Jacquotte; Wei Zheng; Christian C Abnet; Demetrius Albanes; Kimberly Bertrand; Stephanie J Weinstein
Journal:  Am J Epidemiol       Date:  2010-06-18       Impact factor: 4.897

9.  Vitamin-D nutrition and bone mass in adolescent black girls.

Authors:  Sonia A Talwar; Jane Swedler; James Yeh; Simcha Pollack; John F Aloia
Journal:  J Natl Med Assoc       Date:  2007-06       Impact factor: 1.798

10.  Evaluation of vitamin D repletion regimens to correct vitamin D status in adults.

Authors:  Kara J Pepper; Suzanne E Judd; Mark S Nanes; Vin Tangpricha
Journal:  Endocr Pract       Date:  2009-03       Impact factor: 3.443
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.